
ãè¡ãé«ã®èµ·æºããâ人äœã®æ·±å±€ã«å®¿ãç¥ç§ã®åâ
第1ç« ãè¡ã¯âæµããèäœâã§ãã
ãè¡æ¶²ã¯ãæµåããèäœã§ãããèäœã¯ã鿢ããè¡æ¶²ã§ããã
ãã€ãã®çç©åŠè
ã§ããå²åŠè
ã§ããã£ãã®ã¥ã³ã¿ãŒã»ãšã³ããŒã¬ã€ã³å士ïŒDr. GÃŒnther EnderleinïŒã®ãã®èšèã«ã¯ã人éãšããååšã®æ¬è³ªãåçž®ãããŠããŸãã
ç§ãã¡ã¯åŸã
ã«ããŠããè¡ããšã¯äœå
ãæµããèµ€ãæ¶²äœââã€ãŸããé
žçŽ ãæ é€ãéã³ãèå»ç©ãååããâ鿬ã·ã¹ãã âã®ãããªãã®ãšããŠããæããŠããŸããã
ããããããè¡ãã®ãã®ããèäœã®æ£äœãã ãšãããã©ãã§ããããã
å®éãç§ãã¡ã®é«ã«ã¯ããã5ãªããã«ã®è¡æ¶²ãååšãããã®ãã¡çŽ44ïŒ
ãæ§æããŠããã®ãèµ€è¡çã§ãã
ãã®èµ€è¡çã¯ãé©ãã¹ãååšã§ãã
â èµ€è¡çâââæ žâã®ãªã现è
èµ€è¡çã¯äžè¬çã«ã现èããšããŠå®çŸ©ãããŠããŸãããå®ã¯æ žãæããªããšããç¹æ®ãªæ§è³ªãæã£ãŠããŸãã
éåžžã现èãšãããã®ã¯æ žãæã¡ãããã«DNAãªã©ã®èšèšå³ãæ ŒçŽãããŠããŸãã
ãšãããèµ€è¡çã«ã¯ããããããŸãããããã«ããšãã«ã®ãŒå·¥å Žãšããããããã³ã³ããªã¢ãååšããŸããã
ããã§ããèµ€è¡çã¯äººäœã§æãå€ãååšããâ现èâã§ããã1æ¥ã«ããã2,000ååã骚é«ã§æ°ãã«ç£çãããŠããŸãã
ãã®é©ç°çãªåçèœåã¯ãçåœã®æ ¹å¹¹ãæ¯ããŠãããšãã£ãŠãéèšã§ã¯ãããŸããã
â èµ€è¡çã®âæ£äœâã¯ãã¢ã°ããã³ã®å¡
èµ€è¡çã®æ§æèŠçŽ ã詳ããèŠãŠã¿ããšãæ°ŽåãçŽ2/3ãæ®ãã®çŽ97%ããã¢ã°ããã³ãšããæ§æã«ãªã£ãŠããŸãã
ã€ãŸããèµ€è¡çãšã¯ã»ãŒãã¢ã°ããã³ã®å¡ãšãããŸãã
ãã¢ã°ããã³ã¯ãéåãå«ãã ç¹æ®ãªã¿ã³ãã¯è³ªã§ãé
žçŽ ãäºé
žåççŽ ãåžçã»èŒžéããæ©èœãæã£ãŠããŸãã
ãã®åãã«ãããç§ãã¡ã®å
šèº«ã®çްèã¯çããããã®ãšãã«ã®ãŒïŒATPïŒãç£çã§ããŠããã®ã§ãã
â èµ€è¡çã®â黿°çæ§è³ªâãšçåœã®åŸ®çŽ°ãªæµã
ãŸããèµ€è¡çã¯è² é»è·ïŒãã€ãã¹ïŒã垯ã³ãŠãããé°ã€ãªã³ã®ãããªãµããŸããããŸãã
ãã®æ§è³ªãããããã«ãèµ€è¡çå士ãé©åºŠãªè·é¢ãä¿ã¡ãè¡æ¶²ããµã©ãµã©ãšæµããã®ã§ãã
ããã§éèŠãªã®ã¯ãè¡æ¶²ã¯åãªãç©ççãªæ¶²äœã§ã¯ãªããšããããšã
è¡æ¶²ã«ã¯é»è·ãããããã®æµãã«ã¯âãšãã«ã®ãŒâã宿ã£ãŠããŸãã
äžéšã®ç ç©¶è
ãå»åž«ã®äžã«ã¯ãèµ€è¡çããããããã现èã®åé§äœã§ãããå¿
èŠã«å¿ããŠçœè¡çããªã³ãçãããã«ã¯å
è现èã«ååããå¯èœæ§ããããšãã説ãæå±ããŠããŸãïŒåå³¶åŠèª¬ïŒã
ãã®èãæ¹ã¯çŸä»£ã®äž»æµç§åŠããã¯åŠå®ãããŠããŸããããã®çŽèгçãªãªã¢ãªãã£ã«ã¯ç¡èŠã§ããªãé
åããããŸãã
â èµ€è¡çã®ç Žå£ãšåçââçåœã®ãµã€ã¯ã«
éåã«ãã£ãŠèµ€è¡çã¯äžéšç Žå£ãããããšããããŸãã
ããããããã¯çåœã«ãšã£ãŠâæå€±âã§ã¯ãªããâåçâã®å§ãŸããªã®ã§ãã
å£ããèµ€è¡çã¯èèãèŸèãªã©ã§åŠçãããæ°ããªèµ€è¡çã骚é«ããçãŸããŸãã
ãã®åçãæ¯ããéµãšãªãã®ãæ é€ïŒéã»ãã¿ãã³ã»ããã©ã«ïŒã§ãããç§ãåŸã«ç޹ä»ããææ©ã²ã«ãããŠã ããã°ãã·ãŠã ãããã«å€§ããé¢ãã£ãŠããŸãã
ã€ãŸããèµ€è¡çã®ãµã€ã¯ã«ãšã¯ããŸãã«ç Žå£ãšåµé ã®è±¡åŸŽã§ãããç§ãã¡ãããŸããã«çããŠãã蚌ã§ãããã®ã§ãã
å «äºããäŒæ¯ããŠãæããªãé«ã®äžèª¿ãæããããè¡ããæµåãããèµ€è¡çã®ç Žå£ãšåçãå¿ãããªã
â çºæ± åïŒkintsuzuikeïŒ@MTR Method LabÂ®ïž (@kintsuzuike) July 15, 2021
第2ç« ãèµ€è¡çãšãšãã«ã®ãŒã®é¢ä¿
è¡ã¯ãéã¶ã ãã§ã¯ãããŸãããèµ€è¡çã¯ãç§ãã¡ã®çåœæŽ»åã«æ¬ ãããªãããšãã«ã®ãŒããã®ãã®ãæ¯ããååšã§ããããŸãã
â ATPãšé žçŽ ã®éæ¬åœ¹ââèµ€è¡çã®äœ¿åœ
ãšãã«ã®ãŒã®é貚ãšåŒã°ãããATPïŒã¢ããã·ã³äžãªã³é
žïŒãã¯ãçèãåããã«ããå
èãåãããã«ããè³ã䜿ãã«ãå¿
èŠãªç©è³ªã§ãã
ãããŠãã®ATPãäœãåºãã«ã¯ãäœãããé
žçŽ ãäžå¯æ¬ ã§ãã
ãã®é
žçŽ ããèºããå
šèº«ãžãšéãã§ãããŠããã®ãããããèµ€è¡çãªã®ã§ãã
èµ€è¡çã®äžã«ååšãããã¢ã°ããã³ã¯ãèºã§é
žçŽ ãåã蟌ã¿ããããå¿
èŠãªçްèãžãšå±ããŠãããŸãã
ãããŠã现èã®ããã³ã³ããªã¢ã§é
žçŽ ã䜿ãããATPãç£çãããã
ãããã人éã®çåœæŽ»åã®æ ¹æ¬çãªæµãã§ãã
ãã®æµããæ»ãã°ãé
žæ¬ ãç²åŽãççãçã¿ãžãšã€ãªãã£ãŠãããŸãã
â é žæ¬ ãçã¿ãçãä»çµã¿
è¡æµãæªããªããé žçŽ äŸçµŠãäžè¶³ãããšçèã¯ãšãã«ã®ãŒãç£çã§ããããATPæ¬ ä¹ç¶æ ãã«é¥ããŸãã
ãã®çµæãçæçž®ïŒçèã®ç¡¬çŽïŒãèµ·ããããããªããŸãã
ããã«ãé
žæ¬ ç¶æ
ã®çèããã¯ãããã©ãžããã³ããšãã匷åãªçºçç©è³ªãæŸåºãããŸãã
ãã®ç©è³ªã¯ãéåžžã®çã¿ç©è³ªã§ããããã¹ã¿ã°ã©ã³ãžã³ãããé¥ãã«åŒ·åã§ãã
æ
¢æ§çãªè©ãããè
°çããããã¯çé çã®äžéšã¯ããŸãã«ãã®é
žæ¬ æ§çŒçã«ãã£ãŠåŒãèµ·ããããŠããå¯èœæ§ããããŸãã
çã¿ãšã¯ãäœããã®âãšãã«ã®ãŒäžè¶³âãšãããµã€ã³ã§ãããã®ã§ãã